X
  • SULFA-TERRA Oral Solution Powder
  • SULFA-TERRA Oral Solution Powder

SULFA-TERRA Oral Solution Powder

  • : (s)
  • : (s) / Month
  • : Medical Products Medicines
  • :
  • :
  • : Turkey
MT SAGLIK URUNLERI A.S.
  • Not Verified
  • Istanbul / Turkey
  • Established 2005
View Company

Description

SULFA-TERRA Oral Solution Powder is a reinforced sulfonamide combination based on a mixture of Sulfadimetoxin Sodium and Oxytetracycline Hydrochloride in balanced proportions. The combination of aminoacyl-tRNA in the sulfadimethoxin sodium bacterial cell and binding to the 30 S ribosomal subunit located in the bacterial cell in oxytetracycline hydrochloride replaces the folic acid biosynthesis necessary for cell proliferation by nucleic acid synthesis thus inhibiting their binding to the mRNA-ribosomal complex, thereby inhibiting the addition of new amino acid molecules to the peptide chain, thereby blocking protein synthesis. Thus, bacterial pathogens of the synergistic type in susceptible pathogenic bacteria and in some cases a bactericidal effect are formed, and a broad antibacterial spectrum, including most gram positive and gram negative bacteria, is provided.

Sulfonamide + oxytetracycline combinations are mainly susceptible bacteria:

-Gram positive aerobes: Bacillus spp., Corynebacterium spp., Erysipelothrix rhusiopathia, Listeria monocytogenes, staphylococcus aureus, Streptococcus spp., Actinomyces spp.

Negative anerobes: Actinobacillus spp., Bordetella spp., Francisella tularensis, haemophilus spp., Pasteurella multocida, P. Haemolytica, Campylobacter fetus, Bornelia spp., Leptospira spp., Moraxella bovis, E. coli. Salmonella spp., Klebsiella spp., Proteus sp., Yersinia spp.,

Rickettsia spp., Pseudomonas aeroginosa. Mycoplasma spp., Mycobacterium spp., Serratia spp., Are considered resistant.

ShippingDetail
PackagingDetail